BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 23747030)

  • 1. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B.
    Su ZJ; Yu XP; Guo RY; Ming DS; Huang LY; Su ML; Deng Y; Lin ZZ
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):437-44. PubMed ID: 23747030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
    Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
    J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of Th17/Treg ratio in peripheral blood of patients with chronic hepatitis B].
    Geng X; Zhang B; Zhou W; Liang J; Wang L; Wang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Dec; 30(12):1304-6. PubMed ID: 25481191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
    Chen LY; Zhu LY; Yang BS; Bi MR; Yan BZ; Wang W; Ma YJ
    Hepatogastroenterology; 2012; 59(120):2582-6. PubMed ID: 22626879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.
    Xue-Song L; Cheng-Zhong L; Ying Z; Mo-Bin W
    BMC Gastroenterol; 2012 May; 12():43. PubMed ID: 22548790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
    J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment.
    Zhang JY; Song CH; Shi F; Zhang Z; Fu JL; Wang FS
    PLoS One; 2010 Nov; 5(11):e13869. PubMed ID: 21079784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of entecavir on peripheral blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir.
    Zhang L; Wang Q; Zhao P; Hu X; Jiang Y
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):514-23. PubMed ID: 24773272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B.
    Liu B; Gao W; Zhang L; Wang J; Chen M; Peng M; Ren H; Hu P
    Int Immunopharmacol; 2017 May; 46():48-55. PubMed ID: 28259000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study.
    Yang X; Li J; Liu J; Gao M; Zhou L; Lu W
    Medicine (Baltimore); 2017 Jun; 96(23):e7064. PubMed ID: 28591041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients.
    Wu W; Li J; Chen F; Zhu H; Peng G; Chen Z
    J Gastroenterol Hepatol; 2010 Apr; 25(4):750-7. PubMed ID: 20492330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-35 modulates the balance between viral specific CD4
    Yang L; Jia S; Shao X; Liu S; Zhang Q; Song J; Wang W; Jin Z
    Virol J; 2019 Apr; 16(1):48. PubMed ID: 30992023
    [TBL] [Abstract][Full Text] [Related]  

  • 15.  Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B.
    Tian ZF; You ZL; Yi H; Kuang XM; Wang YM
    Ann Hepatol; 2016; 15(2):174-82. PubMed ID: 26845594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure.
    Zhang GL; Xie DY; Lin BL; Xie C; Ye YN; Peng L; Zhang SQ; Zhang YF; Lai Q; Zhu JY; Zhang Y; Huang YS; Hu ZX; Gao ZL
    J Gastroenterol Hepatol; 2013 Mar; 28(3):513-21. PubMed ID: 23215950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
    Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
    Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
    El-Badawy O; Sayed D; Badary MS; Abd-Alrahman ME; El-Feky MA; Thabit AG
    Hum Immunol; 2012 Apr; 73(4):335-41. PubMed ID: 22342871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.